Alzamend Neuro

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alzamend Neuro and other ETFs, options, and stocks.

About ALZN

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. 

CEO
Stephan Jackman
CEOStephan Jackman
Employees
7
Employees7
Headquarters
Atlanta, Georgia
HeadquartersAtlanta, Georgia
Founded
2016
Founded2016
Employees
7
Employees7

ALZN Key Statistics

Market cap
7.08M
Market cap7.08M
Price-Earnings ratio
-0.42
Price-Earnings ratio-0.42
Dividend yield
Dividend yield
Average volume
166.19K
Average volume166.19K
High today
$1.95
High today$1.95
Low today
$1.82
Low today$1.82
Open price
$1.90
Open price$1.90
Volume
53.66K
Volume53.66K
52 Week high
$10.17
52 Week high$10.17
52 Week low
$1.58
52 Week low$1.58

Stock Snapshot

With a market cap of 7.08M, Alzamend Neuro(ALZN) trades at $1.86. The stock has a price-to-earnings ratio of -0.42.

During the trading session on 2026-03-18, Alzamend Neuro(ALZN) shares reached a daily high of $1.95 and a low of $1.82. At a current price of $1.86, the stock is +2.1% higher than the low and still -4.6% under the high.

Trading activity shows a volume of 53.66K, compared to an average daily volume of 166.19K.

Over the past 52 weeks, Alzamend Neuro(ALZN) stock has traded between a high of $10.17 and a low of $1.58.

Over the past 52 weeks, Alzamend Neuro(ALZN) stock has traded between a high of $10.17 and a low of $1.58.

ALZN News

TipRanks 2d
Alzamend Neuro initiates Phase II trial of AL001 study

Alzamend Neuro (ALZN) announced the initiation of its Phase II clinical trial evaluating AL001 in patients diagnosed with BD type 1. The trial is being conducte...

People also own

Based on the portfolios of people who own ALZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.